← Leaderboards
Jeremy Michael Rock
Rockefeller University
$5,755,046
Attributed
$6,903,093
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.5M · FY2018–25$5M$3.8M$2.5M$1.3M$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,903,093 · 4
By mechanism
DP2$2,542,500 · 1
R01$2,296,095 · 1
U19$2,064,498 · 2
Top collaborators
- Eric Joseph Rubin3 shared
Most similar at Rockefeller University
Same institution · by research overlap
- Seth A Darst$25,373,446
- Gilla Kaplan$13,617,442
Others in their field
Other Emerging Leaders on “Genes”
- Leonard Freedman · Leidos Biomedical Research, Inc.$97,908,773
- Yunda Huang · Fred Hutchinson Cancer Center$51,342,169
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Lynn Briscoe · Leidos Biomedical Research, Inc.$41,311,588
- Mathangi Thiagarajan · Leidos Biomedical Research, Inc.$37,695,154
- Evan Z Macosko · Broad Institute, Inc.$32,734,698
Research focus
GenesAntibioticsPharmaceutical PreparationsBiologicalMycobacterium TuberculosisGeneticDrug ResistanceGrowthOrganismMycobacterialScreeningMutationBacterial GenesResponseImmune SystemCrispr InterferenceBiochemicalBase PairingGene TargetingBacterial GeneticsGenetic ManipulationGenomeClinical Drug DevelopmentGenerations
Grant awards (9)
Molecular mechanisms of inherent drug resistance in non-tuberculous mycobacteria$768,176
R01 · FY2025 · AI
Bacterial Genetics Core D$290,926
U19 · FY2025 · AI · contact PI
Molecular mechanisms of inherent drug resistance in non-tuberculous mycobacteria$768,176
R01 · FY2024 · AI
Bacterial Genetics Core D$410,656
U19 · FY2024 · AI · contact PI
Molecular mechanisms of inherent drug resistance in non-tuberculous mycobacteria$759,743
R01 · FY2023 · AI
Bacterial Genetics Core D$410,656
U19 · FY2023 · AI · contact PI
Bacterial Genetics Core D$549,684
U19 · FY2022 · AI · contact PI
Bacterial Genetics Core D$402,576
U19 · FY2021 · AI · contact PI
Towards a molecular understanding of persistent tuberculosis infection$2,542,500
DP2 · FY2018 · AI · contact PI